iFrame.AI – Discover What Matters

ALL MEDICAL CODES IN CATEGORY Chemotherapy Drugs

2025 HCPCS code J9061

Injection, amivantamab-vmjw, 2 mg

2025 HCPCS code J9216

Injection, interferon gamma 1-b, 3 million units

2025 HCPCS code J9281

Mitomycin pyelocalyceal instillation, 1 mg. This code represents one milligram of mitomycin, an anticancer antibiotic, administered into the renal pelvis.

2025 HCPCS code J9043

Injection, cabazitaxel, 1 mg

2025 HCPCS code J9299

Injection, nivolumab, 1 mg

2025 HCPCS code J9999

Not otherwise classified, antineoplastic drug.

2025 HCPCS code J9202

Goserelin acetate implant, per 3.6 mg

2025 HCPCS code J9213

Injection, interferon, alfa-2a, recombinant, 3 million units

2025 HCPCS code J9058

Injection, bendamustine hydrochloride (Apotex), 1 mg

2025 HCPCS code J9033

Injection, bendamustine HCl (Treanda), 1 mg

2025 HCPCS code J9144

Injection, daratumumab, 10 mg and hyaluronidase-fihj. One billable unit represents 10 mg of daratumumab with hyaluronidase-fihj.

2025 HCPCS code J9056

Injection, bendamustine hydrochloride (Vivimusta), 1 mg

2025 HCPCS code J9214

Injection, interferon alfa-2b, recombinant, 1 million units.

2025 HCPCS code J9206

Injection, irinotecan, 20 mg

2025 HCPCS code J9280

Mitomycin injection, 5 mg

2025 HCPCS code J9210

Injection, emapalumab-lzsg, 1 mg

2025 HCPCS code J9063

Injection, mirvetuximab soravtansine-gynx, 1 mg. This code represents 1 mg of mirvetuximab soravtansine–gynx, administered intravenously to treat ovarian, fallopian tube, or primary peritoneal cancer.

2025 HCPCS code J9075

Injection, cyclophosphamide, not otherwise specified, 5 mg.

2025 HCPCS code J9317

Injection, sacituzumab govitecan-hziy, 2.5 mg

2025 HCPCS code J9268

Injection, pentostatin, 10 mg. This code represents the drug pentostatin for intravenous injection, with one unit equaling 10 mg.

2025 HCPCS code J9318

Romidepsin, non-lyophilized, 0.1 mg injection.

2025 HCPCS code J9073

Injection, cyclophosphamide (Ingenus), 5 mg.

2025 HCPCS code J9071

Injection, cyclophosphamide (AuroMedics), 5 mg.

2025 HCPCS code J9246

Injection, melphalan (Evomela), 1 mg

2025 HCPCS code J9120

Injection, dactinomycin, 0.5 mg.

2025 HCPCS code J9098

Injection, cytarabine liposome, 10 mg.

2025 HCPCS code J9270

Injection, plicamycin, 2.5 mg

2025 HCPCS code J9074

Injection, cyclophosphamide (sandoz), 5 mg

2025 HCPCS code J9312

Injection, rituximab, 10 mg

2025 HCPCS code J9316

Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg.

2025 HCPCS code J9322

Injection, pemetrexed (BluePoint), not therapeutically equivalent to J9305, 10 mg.

2025 HCPCS code J9286

Injection, glofitamab-gxbm, 2.5 mg

2025 HCPCS code J9311

Injection, rituximab, 10 mg

2025 HCPCS code J9331

Injection, sirolimus protein-bound particles, 1 mg.

2025 HCPCS code J8565

Gefitinib, 250 mg

2025 HCPCS code J9207

Injection, ixabepilone, 1 mg

2025 HCPCS code J9030

BCG live intravesical instillation; 1 mg.

2025 HCPCS code J9352

This HCPCS code represents the supply of 0.1 mg of trabectedin, a chemotherapy drug used to treat certain types of sarcoma.

2025 HCPCS code J9354

Ado-trastuzumab emtansine (1 mg) injection for intravenous administration.

2025 HCPCS code J9393

Injection, fulvestrant (Teva), 25 mg; not therapeutically equivalent to J9395.

2025 HCPCS code J9356

One unit of J9356 represents 10 mg of trastuzumab and hyaluronidase-oysk administered subcutaneously for HER2-positive breast and gastric cancers.

2025 HCPCS code J9381

This HCPCS code represents a 5 mcg dose of teplizumab-mzwv, administered intravenously to delay type 1 diabetes.

2025 HCPCS code J9055

Injection, cetuximab, 10 mg.

2025 HCPCS code J9264

This HCPCS code represents 1 mg of paclitaxel protein-bound particles for injection.

2025 HCPCS code J9249

This HCPCS code represents 1 mg of melphalan (Apotex) injection.

2025 HCPCS code J9324

Injection, pemetrexed (Pemrydi RTU), 10 mg.

2025 HCPCS code J9309

This HCPCS code represents 1 mg of polatuzumab vedotin-piiq administered intravenously.

2025 HCPCS code J9022

This HCPCS code represents 10 mg of atezolizumab (Tecentriq), a monoclonal antibody administered intravenously for treating various cancers, including bladder cancer.

2025 HCPCS code J9219

Leuprolide acetate implant, 65 mg; a hormonal therapy drug used to treat advanced prostate cancer.

2025 HCPCS code J9205

J9205 represents 1 mg of irinotecan liposome injection, used in treating pancreatic adenocarcinoma.

Enterprise Edition

Upgrade for detailed insurance, legislation, and other documents analytics for individual cases; real-time analysis of the datasets from your EHR, CRM, ERP, or other software; and more Enterprise Features.